Cyclerion Therapeutics (CYCN) Current Assets (2018 - 2025)

Cyclerion Therapeutics' Current Assets history runs 8 years deep, the most recent figure standing at $4.6 million for Q4 2025.

• In Q4 2025, Current Assets rose 9.7% year-over-year to $4.6 million; the TTM figure through Dec 2025 stood at $4.6 million (up 9.7% YoY), while the FY2025 annual figure was $4.6 million, up 9.7% from the prior year.
• Current Assets was $4.6 million for Q4 2025 at Cyclerion Therapeutics, down from $5.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $73.0 million in Q2 2021 to a low of $3.5 million in Q3 2024.
• Historically, Current Assets has averaged $20.9 million across 5 years, with a median of $8.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Current Assets slumped 80.54% in 2023, then jumped 42.76% in 2025.
• A 5-year view of Current Assets shows it stood at $55.5 million in 2021, then tumbled by 73.28% to $14.8 million in 2022, then plunged by 45.86% to $8.0 million in 2023, then slumped by 47.35% to $4.2 million in 2024, then climbed by 9.7% to $4.6 million in 2025.
• The last three Current Assets figures came in at $4.6 million (Q4 2025), $5.1 million (Q3 2025), and $4.0 million (Q2 2025), per Business Quant data.